Similar articles

• [Extrapancreatic effects of sulfonylurea compounds. II. Comparison of equimolar concentrations of tolbutamide, glibornuride, hydroxymethyltolbutamide, carboxytolbutamide, and carboxyglycylamide with reference to their blood-sugar-decreasing and antilipolytic effect on completely pancreatectomized dogs, chronically treated insulin].

  Beyer J, Cordes U, Sell G, Krall H, Schöffling K. Beyer J, et al. Arzneimittelforschung. 1972 Dec;22:Suppl 12A:2172. Arzneimittelforschung. 1972. PMID: 4679247 German. No abstract available.
• [Glibornurid in treatment of diabetes mellitus].

  Rojszykowa E, Wrzesimski W. Rojszykowa E, et al. Pol Tyg Lek. 1974 Jan 14;29(2):63-6. Pol Tyg Lek. 1974. PMID: 4820789 Polish. No abstract available.
• Clinical comparison between glipentide (Staticum) and glibenclamide in diabetics.

  Moncada Lorenzo E, Garcia RV, Barberia Layana JJ, Morant Ciscard JA, Calleja Canelas A. Moncada Lorenzo E, et al. Curr Ther Res Clin Exp. 1977 Jan;21(1):50-7. Curr Ther Res Clin Exp. 1977. PMID: 401712 Clinical Trial. No abstract available.
• [25 years of diabetic treatment by oral hypoglycemic agents: successes and failures].

  Tattersall RB. Tattersall RB. Journ Annu Diabetol Hotel Dieu. 1984:183-91. Journ Annu Diabetol Hotel Dieu. 1984. PMID: 6443219 Review. French. No abstract available.
• Glibenclamide, a new sulphonylurea: whither oral hypoglycaemic agents?

  Marble A. Marble A. Drugs. 1971;1(2):109-15. doi: 10.2165/00003495-197101020-00001. Drugs. 1971. PMID: 4999930 Review. No abstract available.